Owens & Minor Announces Third Quarter 2024 Earnings Release Date and Conference Call

Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2024 on Monday, November 4, 2024, before trading begins on the New York Stock Exchange.

The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917.

All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can be accessed following the presentation at the link provided above.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram®, and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™. Learn more at https://www.owens-minor.com, follow @Owens_Minor on X and connect on LinkedIn at https://www.linkedin.com/company/owens-&-minor/.

OMI-CORP

OMI-IR

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  223.07
+0.53 (0.24%)
AAPL  274.05
-0.06 (-0.02%)
AMD  207.99
+0.41 (0.20%)
BAC  54.91
-0.42 (-0.77%)
GOOG  307.10
-2.22 (-0.72%)
META  652.60
+5.09 (0.79%)
MSFT  475.25
+0.43 (0.09%)
NVDA  176.96
+0.67 (0.38%)
ORCL  187.76
+2.84 (1.54%)
TSLA  479.40
+4.09 (0.86%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.